← hubDrugs

Dimenhydrinate

Discover related

3 sources

← All substances
🔗 MergedCompareTripSitPharmacologyDrugCentral

How the databases line up — = agree, partial, differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).

Show:
TripSitPharmacologyDrugCentral
Classification
Class / category
Also known as
dimenhydrinategravol
Safety
Dose · Oral
Light100–250 mg
Duration
Onset30–90 minutes
Total5–8 hours
Pharmacology
Receptor activity
Histamine H1 receptorMuscarinic acetylcholine receptor M4Muscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M25-hydroxytryptamine receptor 2AMuscarinic acetylcholine receptor M55-hydroxytryptamine receptor 2CSigma non-opioid intracellular receptor 15-hydroxytryptamine receptor 2BAlpha-1D adrenergic receptorAlpha-2A adrenergic receptorSodium-dependent dopamine transporterSodium-dependent noradrenaline transporterAlpha-2B adrenergic receptorUnchecked
HRH1HTR2AHTR2BHTR2CADRA1DADRA2AADRA2BCYP2D6CHRM1CHRM2CHRM3CHRM4CHRM5SIGMAR1SLC6A3SLC6A2
Half-lifeThe plasma elimination half life of dimenhydrinate is 5-8 hours.
Protein bindingDimenhydrinate is 70-85% protein bound in plasma.

TripSit summary

A combination of diphenhydramine and a mild stimulant to counteract the drowsiness accompanied by typical medical use of diphenhydramine. Roughly half the potency of DPH. Small doses can relieve motion sickness, reduce body load from opioids or DXM. Becomes a deliriant in high doses, keeping the user awake and often causing dysphoric, realistic hallucinations.

Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.